UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

A national audit of the management pathways for new HIV diagnoses

Kaide, E; Curtis, H; Freedman, A; Croxford, S; Burns, F; Sabin, C; Chadwick, DR; ... BHIVA Audit and Standards Subcommittee, .; + view all (2021) A national audit of the management pathways for new HIV diagnoses. International Journal of STD and AIDS 10.1177/0956462420987450. (In press). Green open access

[thumbnail of Burns_BHIVA_National_Audit_2019.pdf]
Preview
Text
Burns_BHIVA_National_Audit_2019.pdf - Accepted Version

Download (545kB) | Preview

Abstract

The British HIV Association recommends that new diagnoses be reviewed by an HIV specialist within two weeks. NHS England outcome measures include the proportion of new diagnoses commencing antiretroviral therapy (ART) within 91 days. We aimed to review the extent to which these recommendations were followed, to explore the topics discussed with new diagnoses, and to identify reasons behind delayed ART initiation. UK specialist HIV services were invited to retrospectively review the notes of their last 40 new diagnoses over a 15-month period. One-hundred and thirty-two services provided data for 2281 eligible individuals. Most new diagnoses were reviewed by a specialist within two weeks (67.7%) and were commenced on ART within 91 days (83%), however, there were some concerning delays in those tested at home and in general practice. Partner notification and treatment benefits were discussed with most individuals, unlike the availability of community support and U = U (“undetectable equals untransmittable”). Lengthy delays in ART initiation were mostly due to individuals initially declining ART or missing appointments. Our findings suggest a need for more streamlined pathways into HIV care, review of new diagnoses who have not commenced ART within 8 weeks, and protocol development to ensure discussion of relevant topics.

Type: Article
Title: A national audit of the management pathways for new HIV diagnoses
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1177/0956462420987450
Publisher version: https://doi.org/10.1177/0956462420987450
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Europe, antiretroviral therapy, combination antiretroviral therapy, diagnosis, human immunodeficiency virus
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
URI: https://discovery.ucl.ac.uk/id/eprint/10125681
Downloads since deposit
192Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item